ADDERALL XR (Mixed Salts of a Single-entity Amphetamine) and STRATTERA ( Atomoxetine Hydrochloride) Compared to Placebo on Simulated Driving Safety and Performance and Cognitive Functioning in Adults With ADHD

Completed · Phase 3

Conditions studied: Attention Deficit Disorder With Hyperactivity

In brief

Evaluate the efficacy of treatment with ADDERALL XR and STRATTERA compared to placebo on simulated driving safety and performance of young adults with ADHD as measured by Driving Safety Scores derived by the Driving Simulator.

Key facts

Study ID

NCT00557960

Run by

Shire

People needed

36

Starts

2004-02-25

Expected to finish

2004-10-25

Last updated by the study team

2021-05-25

Who can join

Age: 19 and older, up to 25. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• primary diagnosis of ADHD
• not naive to pharmacologic ADHD treatment
• valid driver's license with a minimum of 3 years driving experience

You may not qualify if…

• recent history of drug dependence or substance use disorder
• any specific cardiac condition that would, in the opinion of the investigator, require exclusion
• history of seizure in last 2 years, tic disorder or Tourette's disorder
• female subject is pregnant or lactating

Where it is running

• Washington Neuropsychological Institute, LLC — Washington D.C., District of Columbia, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.